Gabriel Brooks, M.D.

Gabriel Brooks, M.D.

Chief Medical OfficeratSolid Biosciences· In proxies 2024–2025

Pay in FY2025+12% from the year before · Solid Biosciences stock +41.0% the same year

Gabriel Brooks, M.D. was paid $2.3M in FY2025 (Dec), up 12%. Solid Biosciences stock rose 41.0% that year.

Pay$100 in the stock at the end of FY23 → $92
Pay is from the Summary Compensation Table of each Solid Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Solid BiosciencesPublic company · 2 yr
    • Chief Medical Officer2024 – Present · 2 yrStock in role +5%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?